Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PFIZER INC Director's Dealing 2004

Dec 2, 2004

29831_dirs_2004-12-02_069c1fff-ac63-4c40-a951-fc49b3b5718a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PFIZER INC (PFE)
CIK: 0000078003
Period of Report: 2004-11-30

Reporting Person: SHEDLARZ DAVID L (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2004-12-01 Common Stock S 21500 $28.25 Disposed 513468 Direct
2004-12-01 Common Stock S 5500 $28.26 Disposed 507968 Direct
2004-12-01 Common Stock S 3618 $28.27 Disposed 504350 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2004-11-30 Phantom Stock Units SSP $0.00 A 283 Acquired Common Stock (283) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2098 Indirect
Common Stock 26596 Indirect

Footnotes

F1: I hereby disclaim beneficial ownership of all shares held by members of my family.

F2: Each unit represents one phantom share of common stock.

F3: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service.